<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03188809</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT03188809</nct_id>
  </id_info>
  <brief_title>Adductor Canal Block Versus Femoral Nerve Block With Repeated Bolus Doses Arthroplasty</brief_title>
  <official_title>Adductor Canal Block Versus Femoral Nerve Block With Repeated Bolus Doses: Postoperative Analgesia and Functional Outcomes After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kecioren Education and Training Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kecioren Education and Training Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After total knee prosthesis surgery, in the first postopertive days, serious pain complaints
      occur in the patients and this causes many problems, especially mobility limitation. For this
      reason, a strong analgesic is needed. As a part of multimodal analgesia after total knee
      surgery, nerve blocks are frequently preferred. While central nerve blocks are preferred in
      the forefront, peripheral nerve blocks are frequently preferred due to complications related
      to central nerve blocks. Femoral nerve block and adductor channel block are the preferred
      peripheral blocks for total knee prosthesis. Since early mobilization after total hip
      prosthesis is very important, it is aimed to provide sufficient analgesia by making less
      motor block. Previous studies have shown that adductor channel block provides similar
      analgesia with femoral nerve block. Early mobilization, early discharge and the impact on the
      risk of falls are not yet clear, although it is estimated to be in the positive direction.
      Again, previous studies have compared single doses and infusion doses but no repeated bolus
      doses. Repeated bolus doses have been shown to be more effective in studies in which adductor
      channel catheters have been introduced to date to compare infusion and recurrent bolus doses.

      investigators aimed to compare the effects of repeated bolus doses with femoral nerve
      catheter and adductor channel catheter on postoperative pain and muscle strength in patients
      undergoing total knee replasment under spinal anesthesia in this study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After total knee prosthesis surgery, in the first postopertive days, serious pain complaints
      occur in the patients and this causes many problems, especially mobility limitation. For this
      reason, a strong analgesic is needed. As a part of multimodal analgesia after total knee
      surgery, nerve blocks are frequently preferred. While central nerve blocks are preferred in
      the forefront, peripheral nerve blocks are frequently preferred due to complications related
      to central nerve blocks. Femoral nerve block and adductor channel block are the preferred
      peripheral blocks for total knee prosthesis. Since early mobilization after total hip
      prosthesis is very important, it is aimed to provide sufficient analgesia by making less
      motor block. Previous studies have shown that adductor channel block provides similar
      analgesia with femoral nerve block. Early mobilization, early discharge and the impact on the
      risk of falls are not yet clear, although it is estimated to be in the positive direction.
      Again, previous studies have compared single doses and infusion doses but no repeated bolus
      doses. Repeated bolus doses have been shown to be more effective in studies in which adductor
      channel catheters have been introduced to date to compare infusion and recurrent bolus doses.

      investigators aimed to compare the effects of repeated bolus doses with femoral nerve
      catheter and adductor channel catheter on postoperative pain and muscle strength in patients
      undergoing total knee revision under spinal anesthesia in this study. Materials and Methods:
      The patient will be informed about the procedure to be performed before the operation and
      written approval will be given. The patient will be premeditated with 2mg midazolam and
      sedayon and monitored according to routine operating room procedures and total knee
      prosthesis operation under spinal anesthesia. Patients will then be transferred to the
      collection room and ECG, NIBP and SpO2 monitoring and appropriate sterilization will be
      performed, and a grubby femoral nerve catheter with USG will be attached to the other group
      adductor channel catheter. A 20cc 0.25% marcain will be administered in 6 hours, with the
      first dose catheter placed in both groups.

      In the compilation unit, the patient will be infused with IV PCA in the morphine. The bolus
      dose of 1 mg IV of the PC will be adjusted to the duration of 10 minutes of lockout.
      Postoperatively, 3x1 metoclopramide, 4x1 gr / 24h IV paracetamol and 3x50 mg / 24h IV
      dexketoprofen will be administered to each patient.

      In this process, demographic information of the patients, peroperative KH, ABP, SpO2 values
      will be recorded. In the postoperative period, the patient's pain level, opioid requirement,
      motor block and muscle strength will be recorded and compared statistically.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>double blind, randomised, controlled train</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Muscle strength- Quadriceps Muscle strength scale</measure>
    <time_frame>postoperative 48 hour</time_frame>
    <description>Quadriceps Muscle strength scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative analgesia - Visual analog scale</measure>
    <time_frame>72 hour</time_frame>
    <description>Visual analog scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Functional Outcomes</condition>
  <arm_group>
    <arm_group_label>femoral nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 0.25% will be applied to the catheter at 6 hours, when the first dose of catheter is inserted.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>adductor canal block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 0.25% will be applied to the catheter at 6 hours, when the first dose of catheter is inserted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor Canal Block</intervention_name>
    <description>Adductor channel is roughly triangular in cross section and is bounded by three muscles: quadriceps anterolaterally (specifically vastusmedialis), sartorius medially and adductor magnus posteriorly. Within this canal is the femoral artery, femoral vein, the posterior branch of the obturator nerve, and branches of the femoral nerve; specifically the saphenous nerve and nerve to vastus medialis. When the femoral artery is shown by ultrasonography 21 gauge, 50 mm needle in-plane technique and the catheter will be inserted with the peripheral nerve stimulator lateral to the femoral artery. Bupivacaine 0.25% will be applied to the catheter at 6 hours, when the first dose of catheter is inserted.and the catheter will be inserted with the peripheral nerve stimulator lateral to the femoral artery. Bupivacaine 0.25% will be applied to the catheter at 6 hours, when the first dose of catheter is inserted.</description>
    <arm_group_label>adductor canal block</arm_group_label>
    <other_name>saphen nerve block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>femoral nerve block</intervention_name>
    <description>The probe is placed just below the inguinal crease , when the femoral artery is shown by ultrasonography, the femoral nerve stays in the lateral direction and 21 gauge, 50 mm needle will be advanced from the anterior to the posteriomedial with an in-plane technique and the catheter will be inserted by the peripheral nerve stimulator in the lateral femoral artery. Bupivacaine 0.25% will be applied to the catheter at 6 hours, when the first dose of catheter is inserted.</description>
    <arm_group_label>femoral nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA1-2-3 patients

          -  older than 55 years

          -  who undergo elective total knee prosthesis in our hospital

        Exclusion Criteria:

          -  ASA IV patients ,

          -  patients with local anesthesia that we use,

          -  patients with coagulation disorders,

          -  patients with anatomical anomalies,

          -  patients with localized infection in the injection site ,

          -  patients who is incapable of using pca and/ or evaulate VAS scale,

          -  patients with peripheral nerve disease,

          -  patients with different surgical planning,

          -  complicated gonarthrosis patients,

          -  revision planned patients,

          -  patients who refuse to be involved in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>SEDA ILHAN</last_name>
    <phone>+905388342776</phone>
    <email>kurtbeyogluseda@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>SEDA</name>
      <address>
        <city>Ankara</city>
        <state>Kecioren</state>
        <zip>06380</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SEDA ILHAN</last_name>
      <phone>+905388342776</phone>
      <email>kurtbeyogluseda@gmail.com</email>
    </contact>
    <investigator>
      <last_name>SEDA ILHAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>June 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2017</study_first_posted>
  <last_update_submitted>November 3, 2017</last_update_submitted>
  <last_update_submitted_qc>November 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kecioren Education and Training Hospital</investigator_affiliation>
    <investigator_full_name>Seda Ä°lhan</investigator_full_name>
    <investigator_title>resident</investigator_title>
  </responsible_party>
  <keyword>Postoperative Pain</keyword>
  <keyword>Functional Outcomes</keyword>
  <keyword>Total Knee Arthroplasty</keyword>
  <keyword>Adductor Canal Block</keyword>
  <keyword>Femoral Nerve Block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

